PHK
KERX

Point72 Hong Kong’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Point72 Hong Kong’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-13,477
Closed -$51K – 1354
2018
Q2 		$51K Buy
+13,477
New +$65.6K 0.02% 428
2017
Q1 		– Sell
-100
Closed -$1K – 1140
2016
Q4 		$1K Buy
+100
New +$546 ﹤0.01% 824

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PIMJS
PKO Investment Management Joint-Stock Warsaw, Poland $1.38B AUM 59.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Hong Kong's KERX Position: Q3 2018 in Review

Point72 Hong Kong sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2018, closing a stake of 13,477 shares — an estimated $51K sold.

Point72 Hong Kong first reported a position in KERX in Q4 2016 and held it in 2 quarters. The position peaked at $51K in Q2 2018. 123 funds tracked by Wall St. Rank hold KERX as of Q3 2018.

  • Point72 Hong Kong reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
  • Point72 Hong Kong sold 13,477 Keryx Biopharmaceuticals Inc shares in Q3 2018, an estimated $51K.
  • Point72 Hong Kong first reported a position in Keryx Biopharmaceuticals Inc in Q4 2016 and held it in 2 quarters.
  • Point72 Hong Kong's Keryx Biopharmaceuticals Inc position peaked at $51K in Q2 2018.
  • 123 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2018.

Based on Point72 Hong Kong's 13F filing for Q3 2018, filed 14 Nov 2018.